Published on
May 19, 2025
- 15:00 GMT
AION Healthspan Announces First Patient Treated in Phase I/II Clinical Trial for Cell Therapy in Chronic Kidney Disease
The clinical trial, focused on Diabetic Nephropathy and other forms of Chronic Kidney Disease, is underway at the University of Miami. MIAMI, FL, UNITED STATES, May 19, 2025 /EINPresswire.com/ -- AION Healthspan, Inc., a clinical-stage biotechnology …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
